Free Trial

PACS Group (PACS) Competitors

PACS Group logo
$12.47 -0.43 (-3.33%)
Closing price 07/15/2025 03:59 PM Eastern
Extended Trading
$12.46 -0.01 (-0.08%)
As of 07/15/2025 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PACS vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, PRVA, WGS, and VCYT

Should you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

PACS Group vs. Its Competitors

Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

PACS Group has a net margin of 0.00% compared to Guardant Health's net margin of -53.82%.

Company Net Margins Return on Equity Return on Assets
Guardant Health-53.82% N/A -26.77%
PACS Group N/A N/A N/A

Guardant Health currently has a consensus target price of $53.76, suggesting a potential upside of 11.79%. PACS Group has a consensus target price of $34.29, suggesting a potential upside of 174.95%. Given PACS Group's higher possible upside, analysts clearly believe PACS Group is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
0 Sell rating(s)
0 Hold rating(s)
21 Buy rating(s)
0 Strong Buy rating(s)
3.00
PACS Group
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

92.6% of Guardant Health shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Guardant Health had 8 more articles in the media than PACS Group. MarketBeat recorded 9 mentions for Guardant Health and 1 mentions for PACS Group. Guardant Health's average media sentiment score of 1.01 beat PACS Group's score of -0.12 indicating that Guardant Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
PACS Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

PACS Group has higher revenue and earnings than Guardant Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$739.02M8.06-$436.37M-$3.39-14.19
PACS Group$3.11B0.61$112.87MN/AN/A

Guardant Health has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. Comparatively, PACS Group has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500.

Summary

Guardant Health beats PACS Group on 8 of the 13 factors compared between the two stocks.

Get PACS Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PACS vs. The Competition

MetricPACS GroupMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$1.97B$7.25B$5.61B$20.82B
Dividend YieldN/A2.86%4.23%3.65%
P/E RatioN/A34.4428.5227.17
Price / Sales0.6134.57426.1748.12
Price / CashN/A25.1136.0222.28
Price / BookN/A8.098.134.56
Net Income$112.87M$236.06M$3.24B$995.22M
7 Day Performance-2.81%-3.35%0.20%-1.16%
1 Month Performance22.70%-0.38%5.98%3.18%
1 Year Performance-62.00%19.35%26.15%6.83%

PACS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PACS
PACS Group
2.7597 of 5 stars
$12.47
-3.3%
$34.29
+174.9%
-60.7%$1.97B$3.11B0.0032,433
GH
Guardant Health
4.4791 of 5 stars
$49.77
-1.0%
$53.76
+8.0%
+52.5%$6.17B$739.02M-14.682,021Positive News
OPCH
Option Care Health
4.4969 of 5 stars
$30.68
+2.7%
$35.50
+15.7%
+2.1%$5.02B$5.00B24.748,088Positive News
RDNT
RadNet
3.9706 of 5 stars
$56.59
+2.0%
$69.60
+23.0%
-11.5%$4.25B$1.87B-131.6011,021
BTSG
BrightSpring Health Services
1.7487 of 5 stars
$20.31
flat
$24.90
+22.6%
+77.2%$3.57B$11.86B72.5435,000
SHC
Sotera Health
3.1967 of 5 stars
$11.61
-1.6%
$16.00
+37.8%
-6.9%$3.30B$1.10B145.143,000Positive News
SGRY
Surgery Partners
2.4962 of 5 stars
$22.47
+2.0%
$33.56
+49.3%
-15.2%$2.88B$3.11B-14.6915,000
CON
Concentra Group Holdings Parent
2.8281 of 5 stars
$20.23
+1.6%
$28.50
+40.9%
N/A$2.59B$1.90B15.0911,250
PRVA
Privia Health Group
3.927 of 5 stars
$20.89
+2.1%
$28.38
+35.9%
+14.9%$2.55B$1.80B174.101,140
WGS
GeneDx
3.7819 of 5 stars
$82.39
-0.2%
$92.33
+12.1%
+136.8%$2.35B$330.14M-58.431,200Analyst Downgrade
VCYT
Veracyte
3.562 of 5 stars
$26.65
-1.6%
$40.90
+53.5%
+11.7%$2.09B$445.76M65.00790Positive News

Related Companies and Tools


This page (NYSE:PACS) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners